Prescription Required
Authentic Product
India's Leading Generic Pharmacy
Secure Payment
TERIFRAC 750MCG INJECTION 3 ML
TERIFRAC 750MCG INJECTION 3 ML
By INTAS PHARMACEUTICALS LIMITED
MRP
₹
5500
₹3656
33.53 % OFF
Check Delivery
--
Composition
Product Details
About TERIFRAC 750MCG INJECTION 3 ML
- TERIFRAC 750MCG INJECTION 3 ML contains Teriparatide, which is a man-made version of a natural hormone called parathyroid hormone. It is used to treat osteoporosis, a condition where bones become weak and brittle, making them more likely to break (fracture). Fractures caused by osteoporosis can lead to significant pain and make it difficult to move around.
- TERIFRAC 750MCG INJECTION 3 ML works by helping your body build new bone tissue and increasing how strong your bones are (improving bone mineral density). It has also been shown to speed up bone healing after a fracture. It encourages the early formation of a new bone structure called callus, which is the first step in repairing a broken bone, leading to faster and better recovery.
- This medication is typically given as a daily injection under the skin. Using TERIFRAC 750MCG INJECTION 3 ML can significantly lower the risk of future fractures in people with severe osteoporosis. It is a valuable treatment for strengthening bones and improving overall bone health over time, usually prescribed for a limited duration, often around 18 to 24 months, to get the best results while managing potential risks.
- TERIFRAC 750MCG INJECTION 3 ML is not suitable for everyone. Do not use this medication if you have a known allergy to Teriparatide or any other ingredients in the injection. It should also not be used if you have a history of bone cancer (like osteosarcoma), cancer that has spread to your bones, or if you have received radiation therapy that involved your bones.
Uses of TERIFRAC 750MCG INJECTION 3 ML
- Treating osteoporosis that occurs in women after menopause.
- Managing osteoporosis caused by long-term use of steroid medications (like glucocorticoids).
Side Effects of TERIFRAC 750MCG INJECTION 3 ML
Like all medications, TERIFRAC 750MCG INJECTION 3 ML may cause some side effects, although not everyone will experience them.
Safety Advice for TERIFRAC 750MCG INJECTION 3 ML
BreastFeeding
Consult a DoctorWomen should consult a doctor while breastfeeding while taking the TERIFRAC 750MCG INJECTION 3 ML.
Driving
UnsafePeople may experience side effects, including dizziness, drowsiness, or fatigue, after using TERIFRAC 750MCG INJECTION 3 ML. In that case, avoid driving or operating heavy machinery.
Liver Function
Consult a DoctorIf you have a liver condition or are concerned about the safety of TERIFRAC 750MCG INJECTION 3 ML, it is recommended to consult your healthcare provider for personalized advice.
Lungs
Consult a DoctorSuppose you have a pre-existing lung condition or are concerned about the safety of the TERIFRAC 750MCG INJECTION 3 ML in your lungs. Consulting with your healthcare provider for personalized advice is recommended in that case.
Pregnancy
UnsafeThe safety of TERIFRAC 750MCG INJECTION 3 ML use during pregnancy has not been established. If you are pregnant or planning to become pregnant, discussing the potential risks and benefits with your healthcare professional is essential.
Dosage of TERIFRAC 750MCG INJECTION 3 ML
- TERIFRAC 750MCG INJECTION 3 ML is a medication that requires administration by a qualified healthcare professional. This is crucial for ensuring the injection is given correctly and safely.
- It is typically administered as a subcutaneous injection, meaning it is injected just under the skin. The exact site of injection is important and will be chosen by the healthcare provider.
- The precise dosage and the overall duration of treatment with TERIFRAC 750MCG INJECTION 3 ML are carefully determined by the attending physician or nurse.
- This decision is not a one-size-fits-all approach. It is based on a thorough evaluation of several factors specific to the individual patient.
- These factors include the patient's overall health status, their response to treatment, other medications they might be taking, and the specific condition being treated.
- It is essential for patients *not* to attempt to administer this injection themselves. Follow-up appointments may also be necessary to monitor progress and adjust treatment as needed.
How to store TERIFRAC 750MCG INJECTION 3 ML?
- Keep TERIFRAC 750MCG INJ CARTRIDGE 3ML away from the reach of children and pets.
- Store TERIFRAC 750MCG INJ CARTRIDGE 3ML in a refrigerator (2 - 8°C). Do not freeze.
Benefits of TERIFRAC 750MCG INJECTION 3 ML
- Significantly increases bone mineral density and enhances bone strength, directly leading to a reduced risk of fractures and promoting faster bone healing if needed.
- Offers a valuable treatment alternative for individuals who haven't responded well to other osteoporosis therapies, ultimately improving overall quality of life by reducing fracture-related worry and improving mobility.
How to use TERIFRAC 750MCG INJECTION 3 ML
- TERIFRAC 750MCG INJECTION 3 ML is a specialized medication that must be administered under the guidance of a qualified healthcare professional. This injection is typically given daily, usually under the skin (subcutaneously). While some patients may be taught to self-administer the injection after the initial dose under supervision, it is crucial for the healthcare provider to demonstrate the correct technique, including preparing the injection, choosing the site, and proper needle disposal. The exact dosage and the total duration of treatment with TERIFRAC 750MCG INJECTION 3 ML will be determined solely by your doctor. This decision is based on your individual medical condition, bone density levels, response to the medication, and other health factors. Treatment duration is generally limited, often to about 24 months. It is vital to follow the prescribed dosage and schedule precisely and to attend all follow-up appointments. Do not stop or change your treatment without consulting your healthcare provider. They will monitor your progress and adjust the treatment plan as needed to ensure the best possible outcomes for your bone health.
FAQs
Can TERIFRAC 750MCG INJECTION 3 ML be used in individuals with a history of cancer?
TERIFRAC 750MCG INJECTION 3 ML is generally not recommended for individuals with a history of cancer, especially skeletal malignancies or bone metastases. The medication has been associated with an increased risk of osteosarcoma, and its safety in individuals with a history of cancer has not been well established.
Can TERIFRAC 750MCG INJECTION 3 ML be used in men with osteoporosis?
Yes, TERIFRAC 750MCG INJECTION 3 ML can be used in men with osteoporosis. While osteoporosis is more commonly associated with women, men can also develop the condition. It can effectively increase bone density and reduce fracture risk in men with osteoporosis.
Can TERIFRAC 750MCG INJECTION 3 ML be used in individuals with a history of kidney disease?
TERIFRAC 750MCG INJECTION 3 ML does not undergo significant renal excretion so it can be used in individuals with mild to moderate kidney impairment. However, caution is advised in individuals with severe kidney disease, as there is limited data on the safety and effectiveness of this medication in this population.
Can TERIFRAC 750MCG INJECTION 3 ML be used in individuals with a history of fractures?
TERIFRAC 750MCG INJECTION 3 ML is commonly prescribed for individuals with a history of fragility fractures. Fragility fractures occur due to minimal trauma or impact and are often associated with osteoporosis. It helps to increase bone density and reduce the risk of future fractures in individuals with osteoporosis, including those who have previously experienced fractures.
Can TERIFRAC 750MCG INJECTION 3 ML be used as a first-line treatment for osteoporosis?
TERIFRAC 750MCG INJECTION 3 ML is typically not used as a first-line treatment for osteoporosis. It is usually considered when other osteoporosis medications are ineffective, or individuals have a high fracture risk. However, whether it is appropriate as a first-line treatment depends on individual factors and should be discussed with your healthcare provider.
What are the potential long-term effects of TERIFRAC 750MCG INJECTION 3 ML?
The long-term effects of TERIFRAC 750MCG INJECTION 3 ML have yet to be well understood, particularly beyond the recommended treatment duration of 2 years. The risk of osteosarcoma, a potential rare side effect, is one of the main concerns associated with long-term use.
What are the side effects of TERIFRAC 750MCG INJECTION 3 ML?
TERIFRAC 750MCG INJECTION 3 ML may cause side effects, including common ones such as injection site reactions, nausea, dizziness, and headache. Serious side effects, though rare, can include the development of osteosarcoma, a type of bone cancer, and the potential for hypercalcemia, which can lead to symptoms like excessive thirst and muscle weakness.
Does TERIFRAC 750MCG INJECTION 3 ML interact with other drugs?
It is essential to inform your healthcare provider about all prescription and non-prescription medications, vitamins, and herbal supplements you are currently taking before starting treatment with TERIFRAC 750MCG INJECTION 3 ML. This helps identify potential interactions.
What precautions should I take before using TERIFRAC 750MCG INJECTION 3 ML?
Before using TERIFRAC 750MCG INJECTION 3 ML, discuss your full medical history with your doctor, especially if you have bone disorders other than osteoporosis, kidney problems (severe), hyperparathyroidism, or low blood pressure upon standing (orthostatic hypotension). It's generally not recommended if you have a history of bone cancer or metastases. Your doctor will monitor your blood calcium levels. The treatment duration is typically limited to 2 years, and it is not for children. If you are pregnant or breastfeeding, consult your doctor about the risks and benefits.
What is the main ingredient in TERIFRAC 750MCG INJECTION 3 ML?
The main ingredient in TERIFRAC 750MCG INJECTION 3 ML is TERIPARATIDE.
Is TERIFRAC 750MCG INJECTION 3 ML used to treat Osteoporosis?
Yes, TERIFRAC 750MCG INJECTION 3 ML is prescribed for the treatment of Osteoporosis.
Is TERIFRAC 750MCG INJECTION 3 ML used to treat Arthritis?
Yes, TERIFRAC 750MCG INJECTION 3 ML is prescribed for conditions including Arthritis.
Is Terifrac 750mcg Injection safe for pregnant or breastfeeding women?
Terifrac should be avoided during pregnancy or breastfeeding unless absolutely necessary. Always consult your doctor for personalized advice.
References
Ratings & Review
Good service and they have too many varieties of products
shah dhruvi
•
Reviewed on 13-03-2024
(5/5)
Awesome
Pankaj Patel
•
Reviewed on 13-06-2023
(5/5)
Reliable and accessible pharmacy. Courteous and helpful people.
Jigar Jani
•
Reviewed on 29-08-2023
(5/5)
Proper medicine at big saving rate
Mukesh Jain
•
Reviewed on 24-01-2024
(5/5)
Nice experience, always!
Ashutosh Buch
•
Reviewed on 24-02-2023
(5/5)
Marketer / Manufacturer Details
INTAS PHARMACEUTICALS LIMITED
Country of Origin -
India
Alternatives
Customer Also Bought
MRP
₹
5500
₹3656
33.53 % OFF
Quick Links
Related Blogs
Disclaimer
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
India's most trusted generic medicine pharmacy.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered
Authentic Products
All WHO-GMP Certified Medicines
About Medkart Pharmacy
Our Services
Follow Us On
Download the app for free
©2025 Medkart Pharmacy. All Rights Reserved